Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE4.4000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.2300/ 59
- Ask / Lots4.4000/ 5
- Open / Previous Close4.4000 / 4.4000
- Day Range
- 52 Week Range
- Volume889,513
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 1212 | 4.4 |
| 09:34 ET | 700 | 4.38 |
| 09:36 ET | 200 | 4.38 |
| 09:38 ET | 816 | 4.365 |
| 09:39 ET | 4907 | 4.3301 |
| 09:41 ET | 700 | 4.35 |
| 09:43 ET | 500 | 4.35 |
| 09:45 ET | 32050 | 4.33 |
| 09:48 ET | 1000 | 4.355 |
| 09:50 ET | 6900 | 4.3533 |
| 09:52 ET | 1200 | 4.355 |
| 09:54 ET | 3890 | 4.35 |
| 09:56 ET | 8500 | 4.35 |
| 09:57 ET | 6982 | 4.35 |
| 09:59 ET | 32074 | 4.35 |
| 10:01 ET | 31296 | 4.355 |
| 10:03 ET | 2766 | 4.355 |
| 10:06 ET | 900 | 4.36 |
| 10:08 ET | 4149 | 4.375 |
| 10:10 ET | 1140 | 4.355 |
| 10:12 ET | 1291 | 4.35 |
| 10:14 ET | 1356 | 4.355 |
| 10:15 ET | 1200 | 4.3708 |
| 10:17 ET | 8177 | 4.41 |
| 10:19 ET | 7106 | 4.4006 |
| 10:21 ET | 1200 | 4.42 |
| 10:24 ET | 1000 | 4.4 |
| 10:26 ET | 200 | 4.38 |
| 10:28 ET | 100 | 4.38 |
| 10:30 ET | 2339 | 4.385 |
| 10:32 ET | 300 | 4.38 |
| 10:33 ET | 2792 | 4.405 |
| 10:37 ET | 894 | 4.41 |
| 10:39 ET | 400 | 4.41 |
| 10:42 ET | 100 | 4.41 |
| 10:44 ET | 300 | 4.4 |
| 10:46 ET | 400 | 4.4 |
| 10:48 ET | 200 | 4.4 |
| 10:50 ET | 1488 | 4.405 |
| 10:51 ET | 3400 | 4.425 |
| 10:53 ET | 900 | 4.429 |
| 10:55 ET | 1800 | 4.436721 |
| 10:57 ET | 200 | 4.43 |
| 11:00 ET | 5300 | 4.445 |
| 11:02 ET | 1100 | 4.445 |
| 11:04 ET | 72580 | 4.445 |
| 11:06 ET | 5500 | 4.445 |
| 11:08 ET | 21408 | 4.48 |
| 11:09 ET | 3642 | 4.4899 |
| 11:11 ET | 1640 | 4.4899 |
| 11:13 ET | 2850 | 4.485 |
| 11:15 ET | 1300 | 4.48 |
| 11:18 ET | 500 | 4.485 |
| 11:20 ET | 1000 | 4.485 |
| 11:22 ET | 4974 | 4.465 |
| 11:24 ET | 2253 | 4.4506 |
| 11:26 ET | 1450 | 4.465 |
| 11:27 ET | 200 | 4.465 |
| 11:29 ET | 100 | 4.465 |
| 11:33 ET | 200 | 4.46 |
| 11:38 ET | 1300 | 4.465 |
| 11:40 ET | 100 | 4.465 |
| 11:42 ET | 1854 | 4.46 |
| 11:44 ET | 200 | 4.465 |
| 11:47 ET | 5025 | 4.455 |
| 11:49 ET | 200 | 4.455 |
| 11:51 ET | 400 | 4.455 |
| 11:54 ET | 1184 | 4.47 |
| 11:56 ET | 400 | 4.48 |
| 12:00 ET | 460 | 4.475 |
| 12:02 ET | 413 | 4.47 |
| 12:05 ET | 100 | 4.481 |
| 12:07 ET | 300 | 4.485 |
| 12:09 ET | 4137 | 4.485 |
| 12:12 ET | 7089 | 4.485 |
| 12:14 ET | 2019 | 4.495 |
| 12:16 ET | 7600 | 4.46 |
| 12:18 ET | 14754 | 4.46 |
| 12:20 ET | 3957 | 4.485 |
| 12:23 ET | 125 | 4.4899 |
| 12:25 ET | 1100 | 4.48 |
| 12:27 ET | 1925 | 4.485 |
| 12:32 ET | 545 | 4.487 |
| 12:34 ET | 2050 | 4.485 |
| 12:36 ET | 600 | 4.4899 |
| 12:38 ET | 658 | 4.49 |
| 12:41 ET | 600 | 4.495 |
| 12:43 ET | 600 | 4.495 |
| 12:45 ET | 8278 | 4.5 |
| 12:48 ET | 5068 | 4.48 |
| 12:50 ET | 1193 | 4.48 |
| 12:52 ET | 5700 | 4.485 |
| 12:54 ET | 100 | 4.48 |
| 12:56 ET | 600 | 4.48 |
| 12:57 ET | 3590 | 4.47 |
| 12:59 ET | 8151 | 4.455 |
| 01:01 ET | 670 | 4.46 |
| 01:03 ET | 3197 | 4.45 |
| 01:06 ET | 2600 | 4.44 |
| 01:08 ET | 400 | 4.44 |
| 01:10 ET | 500 | 4.445 |
| 01:12 ET | 400 | 4.445 |
| 01:14 ET | 1906 | 4.46 |
| 01:15 ET | 100 | 4.455 |
| 01:19 ET | 2376 | 4.455 |
| 01:21 ET | 300 | 4.455 |
| 01:26 ET | 500 | 4.45 |
| 01:28 ET | 800 | 4.45 |
| 01:30 ET | 100 | 4.45 |
| 01:32 ET | 700 | 4.445 |
| 01:33 ET | 1300 | 4.455 |
| 01:35 ET | 347 | 4.455 |
| 01:37 ET | 629 | 4.455 |
| 01:39 ET | 1270 | 4.445 |
| 01:42 ET | 5100 | 4.4501 |
| 01:44 ET | 100 | 4.46 |
| 01:46 ET | 200 | 4.46 |
| 01:48 ET | 200 | 4.46 |
| 01:51 ET | 100 | 4.455 |
| 01:53 ET | 2599 | 4.45 |
| 01:57 ET | 200 | 4.44 |
| 02:00 ET | 979 | 4.46 |
| 02:06 ET | 1500 | 4.45 |
| 02:09 ET | 602 | 4.46 |
| 02:13 ET | 300 | 4.4592 |
| 02:15 ET | 700 | 4.4594 |
| 02:18 ET | 100 | 4.455 |
| 02:22 ET | 2646 | 4.46 |
| 02:24 ET | 1000 | 4.4607 |
| 02:26 ET | 900 | 4.47 |
| 02:27 ET | 25210 | 4.445 |
| 02:29 ET | 300 | 4.445 |
| 02:31 ET | 3671 | 4.445 |
| 02:36 ET | 1100 | 4.445 |
| 02:38 ET | 1000 | 4.445 |
| 02:40 ET | 316 | 4.45 |
| 02:42 ET | 13283 | 4.43 |
| 02:44 ET | 3635 | 4.445 |
| 02:45 ET | 2400 | 4.44 |
| 02:51 ET | 450 | 4.4399 |
| 02:54 ET | 2099 | 4.435 |
| 02:56 ET | 100 | 4.43 |
| 02:58 ET | 1151 | 4.42 |
| 03:00 ET | 200 | 4.425 |
| 03:02 ET | 900 | 4.43 |
| 03:03 ET | 1792 | 4.405 |
| 03:05 ET | 3700 | 4.4024 |
| 03:07 ET | 1039 | 4.41 |
| 03:12 ET | 2368 | 4.41 |
| 03:14 ET | 500 | 4.4 |
| 03:16 ET | 2400 | 4.4 |
| 03:18 ET | 600 | 4.4 |
| 03:20 ET | 100 | 4.4 |
| 03:21 ET | 10233 | 4.385 |
| 03:23 ET | 3895 | 4.395 |
| 03:27 ET | 4119 | 4.39 |
| 03:30 ET | 600 | 4.395 |
| 03:32 ET | 13866 | 4.39 |
| 03:34 ET | 30844 | 4.4 |
| 03:36 ET | 200 | 4.4 |
| 03:38 ET | 15540 | 4.395 |
| 03:39 ET | 13223 | 4.4 |
| 03:41 ET | 9105 | 4.4 |
| 03:43 ET | 3125 | 4.395 |
| 03:45 ET | 15651 | 4.365 |
| 03:48 ET | 59258 | 4.4 |
| 03:50 ET | 11454 | 4.385 |
| 03:52 ET | 8602 | 4.385 |
| 03:54 ET | 14580 | 4.385 |
| 03:56 ET | 5988 | 4.385 |
| 03:57 ET | 39382 | 4.4 |
| 03:59 ET | 42857 | 4.4 |
Oct 1, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald, from 8:47AM ET on Tuesday Oct 01, 2024 by Dow Jones
8:47AM ET on Tuesday Oct 01, 2024 by Dow Jones
Sep 17, 2024
DJ Mereo BioPharma Group Down Over 9%, on Pace for Largest Percent Decrease Since August 2023 -- Data Talk, from 1:42PM ET on Tuesday Sep 17, 2024 by Dow Jones
1:42PM ET on Tuesday Sep 17, 2024 by Dow Jones
Sep 16, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald, from 12:21PM ET on Monday Sep 16, 2024 by Dow Jones
12:21PM ET on Monday Sep 16, 2024 by Dow Jones
Sep 12, 2024
Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference, from 5:35PM ET on Thursday Sep 12, 2024 by Dow Jones
5:35PM ET on Thursday Sep 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 677.0M | -13.5x | --- |
Applied Therapeutics Inc | 884.3M | -5.1x | --- |
IGM Biosciences Inc | 914.1M | -4.2x | --- |
Perspective Therapeutics Inc | 900.2M | -9.6x | --- |
Arrivent Biopharma Inc | 915.6M | -11.1x | --- |
Oruka Therapeutics Inc | 891.4M | -4.3x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company focused on the development of therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). In addition to the rare disease programs, it has two oncology product candidates in clinical development. Etigilimab is an IgG1 monoclonal antibody which binds to the human T-cell immunoreceptor with Ig and ITIM domains (TIGIT) receptor on immune cells to improve the activation and effectiveness of T-cell and NK cell antitumor activity. Navicixizumab is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Navicixizumab is developed for the treatment of late line ovarian cancer.
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $677.0M |
|---|---|
Revenue (TTM) | $10.4M |
Shares Outstanding | 153.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.97 |
EPS | $-0.33 |
Book Value | $0.46 |
P/E Ratio | -13.5x |
Price/Sales (TTM) | 65.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -416.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
